News | February 08, 2010

On-Pump, Off-Pump Bypass Surgery Yield Similar Results

February 9, 2010 – Off-pump bypass surgery, or “beating heart surgery,” was developed in hopes of creating a safer way to fix cholesterol-clogged coronary arteries. But a major new study suggests that off-pump bypass surgery doesn’t quite measure up to the traditional operation, in which the heart is stopped during the procedure and a heart-lung machine pumps blood through the body, reports the February 2010 issue of the Harvard Heart Letter.

Early reports about off-pump bypass surgery indicated the operation caused less confusion and memory loss afterward, problems that were attributed to the use of the heart-lung machine. Some later, larger, and longer studies supported these findings, while others didn’t. Now, results from a large head-to-head comparison trial are bringing some clarity to the hot debate over which procedure is better.

In the trial, men and women needing bypass surgery were randomly assigned to the on-pump or off-pump operation. At 30 days after the procedure, the results were almost identical — similar numbers of deaths, strokes, and cardiac arrests. One key difference was that 18 percent of the off-pump group ended up getting fewer grafts than planned, compared with 11 percent of the on-pump group. A year later, 9.9 percent of the participants in the off-pump group had died, had a heart attack, or needed another procedure, compared with 7.4 percent in the on-pump group. And participants in both groups scored the same on tests designed to assess memory and thinking skills.

The Harvard Heart Letter notes that off-pump surgery clearly isn’t better than traditional bypass surgery, and on-pump bypass sometimes yields a better or more durable fix. The skill and experience of the surgeon and operating team are probably more important than the type of bypass surgery performed.

For more information:

Related Content

SherpaPak Cardiac Transport System Cleared for Pediatric and Small Donor Hearts
Technology | Cardiovascular Surgery | February 01, 2019
Paragonix Technologies Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) for a design...
Transplanting Pig Hearts Into Humans One Step Closer. A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

News | Cardiovascular Surgery | December 11, 2018
The scientific journal Nature recently published an article from Munich University Hospital which describes the long-...
Bilateral Artery Use Does Not Improve 10-Year CABG Outcomes
News | Cardiovascular Surgery | September 06, 2018
While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary...
Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery | May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Overlay Init